WebMar 30, 2024 · TSRI’s price/sales is 0.17. Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues. WebBelow are the latest news stories about TSR INC that investors may wish to consider to help them evaluate TSRI as an investment opportunity. TSR, Inc. Reports the Promotion of Two …
TSR, Inc. Common Stock (TSRI) Stock Price, Quote, News
WebApr 13, 2024 · Get undefined (TSRI.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments WebApr 11, 2024 · The Fly team scours all sources of company news, from mainstream to cutting edge,then filters out the noise to deliver shortform stories consisting of only … incoming wire payment rbc
TSRI - TSR Inc Stock Price Quote - NASDAQ Morningstar
WebApr 11, 2024 · FRAMINGHAM, MA / ACCESSWIRE / April 11, 2024 / Xenetic Biosciences Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat cancers, today announced it has entered into a Research Funding and Option Agreement (the … WebGet the latest TSR, Inc. (TSRI) stock news and headlines to help you in your trading and investment decisions. WebApr 11, 2024 · Health Canada previously approved Orkambi for CF patients ages two and above. This label expansion follows a similar label change in the US in September 2024. The FDA initially granted Orkambi approval in 2015 as the first medicine to treat the underlying cause of CF for individuals aged 12 or older with two copies of the F508del mutation. incoming wire transfer fee union bank